These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26009263)

  • 1. Acute myeloid leukemia cells MOLM-13 and SKM-1 established for resistance by azacytidine are crossresistant to P-glycoprotein substrates.
    Messingerova L; Imrichova D; Kavcova H; Turakova K; Breier A; Sulova Z
    Toxicol In Vitro; 2015 Oct; 29(7):1405-15. PubMed ID: 26009263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of resistant acute myeloid leukemia SKM-1 and MOLM-13 cells by vincristine-, mitoxantrone- and lenalidomide-induced upregulation of P-glycoprotein activity and downregulation of CD33 cell surface exposure.
    Imrichova D; Messingerova L; Seres M; Kavcova H; Pavlikova L; Coculova M; Breier A; Sulova Z
    Eur J Pharm Sci; 2015 Sep; 77():29-39. PubMed ID: 26002042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of P-glycoprotein in leukemia cells is associated with the upregulated expression of nestin, a class 6 filament protein.
    Coculova M; Imrichova D; Seres M; Messingerova L; Bohacova V; Sulova Z; Breier A
    Leuk Res; 2016 Sep; 48():32-9. PubMed ID: 27479651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decrease in cellular microRNA-27a content is involved in azacytidine-induced P-glycoprotein expression in SKM-1 cells.
    Messingerova L; Imrichova D; Kavcova H; Seres M; Sulova Z; Breier A
    Toxicol In Vitro; 2016 Oct; 36():81-88. PubMed ID: 27396688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
    Farabegoli F; Papi A; Bartolini G; Ostan R; Orlandi M
    Phytomedicine; 2010 Apr; 17(5):356-62. PubMed ID: 20149610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines.
    Nuessler V; Stötzer O; Gullis E; Pelka-Fleischer R; Pogrebniak A; Gieseler F; Wilmanns W
    Leukemia; 1999 Nov; 13(11):1864-72. PubMed ID: 10557064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin up-regulates the expression of breast cancer resistance protein (BCRP) through attenuating the suppression of p53 on NF-κB expression in MCF-7/5-FU cells.
    Wang QP; Wang Y; Wang XD; Mo XM; Gu J; Lu ZY; Pan ZL; Zhu YX
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2036-44. PubMed ID: 23838170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
    Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
    Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multidrug resistance mechanisms in cell line HL-60/VCR].
    Zhu XH; Li JY; Xia XM; Zhu MQ; Geng MJ; Chen L; Zhang JQ
    Ai Zheng; 2002 Dec; 21(12):1310-3. PubMed ID: 12520737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
    Huang Y; Ibrado AM; Reed JC; Bullock G; Ray S; Tang C; Bhalla K
    Leukemia; 1997 Feb; 11(2):253-7. PubMed ID: 9009089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells.
    Svirnovski AI; Shman TV; Serhiyenka TF; Savitski VP; Smolnikova VV; Fedasenka UU
    Hematology; 2009 Aug; 14(4):204-12. PubMed ID: 19635183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-κB-dependent P-glycoprotein upregulation.
    Tan SF; Dunton W; Liu X; Fox TE; Morad SAF; Desai D; Doi K; Conaway MR; Amin S; Claxton DF; Wang HG; Kester M; Cabot MC; Feith DJ; Loughran TP
    J Lipid Res; 2019 Jun; 60(6):1078-1086. PubMed ID: 30962310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug resistance modulators PSC 833 and CsA show differential capacity to induce apoptosis in lymphoid leukemia cell lines independently of their MDR phenotype.
    Lopes EC; Garcia M; Benavides F; Shen J; Conti CJ; Alvarez E; Hajos SE
    Leuk Res; 2003 May; 27(5):413-23. PubMed ID: 12620293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of ABCG2-overexpressing cells to conventional chemotherapeutic agent by sunitinib was associated with inhibiting the function of ABCG2.
    Dai CL; Liang YJ; Wang YS; Tiwari AK; Yan YY; Wang F; Chen ZS; Tong XZ; Fu LW
    Cancer Lett; 2009 Jun; 279(1):74-83. PubMed ID: 19232821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells.
    Khan GN; Kim EJ; Shin TS; Lee SH
    Anticancer Res; 2017 May; 37(5):2355-2364. PubMed ID: 28476801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vincristine-induced expression of P-glycoprotein in MOLM-13 and SKM-1 acute myeloid leukemia cell lines is associated with coexpression of nestin transcript.
    Imrichova D; Coculova M; Messingerova L; Sulova Z; Breier A
    Gen Physiol Biophys; 2014; 33(4):425-31. PubMed ID: 24968412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Camptothecin and cisplatin upregulate ABCG2 and MRP2 expression by activating the ATM/NF-κB pathway in lung cancer cells.
    Ke SZ; Ni XY; Zhang YH; Wang YN; Wu B; Gao FG
    Int J Oncol; 2013 Apr; 42(4):1289-96. PubMed ID: 23381786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
    Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.